Optimising CN54gp140 plasmid delivery by comparing intramuscular and intradermal vaccination combinations with and without electroporation

Ítems similars

• Optimising CN54gp140 plasmid delivery by comparing intramuscular and intradermal vaccination combinations with and without electroporation
  per: Mann JF, et al.
  Publicat: (2012-09-01)
• P11-11. Stable lyophilised gel vehicles for vaginal administration of recombinant C-clade HIV-1 trimeric CN54gp140
  per: Shattock RJ, et al.
  Publicat: (2009-10-01)
• Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers
  per: Frank Msafiri, et al.
  Publicat: (2020-11-01)
• P11-12. A novel vaginal ring device for the sustained delivery of recombinant C-clade HIV-1 CN54gp140
  per: Shattock R, et al.
  Publicat: (2009-10-01)
• Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.
  per: Paul F McKay, et al.
  Publicat: (2014-01-01)